Effects of early treatment with statins on short-term clinical outcomes in acute coronary syndromes

A study to evaluate relevant outcomes of patients from randomized controlled trials comparing early statin therapy with placebo or usual care at 1 and 4 months following acute coronary syndrome (ACS) is illustrated. Based on available evidence it is concluded that initiation of statin therapy within 14 days following onset of ACS does not reduce death, myocardial infarction, or stroke up to 4 months.